Crescent Capital Consulting’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$11K Hold
100
﹤0.01% 364
2021
Q3
$13K Sell
100
-400
-80% -$52K ﹤0.01% 389
2021
Q2
$68K Buy
500
+100
+25% +$13.6K 0.01% 247
2021
Q1
$54K Hold
400
0.01% 268
2020
Q4
$56K Buy
+400
New +$56K 0.01% 236